Literature DB >> 10469044

Enhancement of lectin pathway haemolysis by immunoglobulins.

C Suankratay1, Y Zhang, D Jones, T F Lint, H Gewurz.   

Abstract

We recently reported that indicator sheep erythrocytes (E) coated with mannan and sensitized with mannan-binding lectin (MBL) (E-M-MBL) are lysed by human serum in the absence of calcium via the lectin pathway of complement activation by a process which requires alternative pathway amplification and is associated with increased binding of and control by complement regulatory proteins C4 bp and factor H. In the present study, we investigated the effect of immunoglobulin (Ig) on this haemolysis. Co-sensitization of indicator E with anti-E haemolysin led to threefold enhancement of lectin pathway haemolysis in the absence of calcium, associated with increased binding of C3 and C5. Lysis was enhanced approximately twofold when E-M-MBL were chemically or immunologically coated with IgM or IgA, and fourfold when coated with IgG, prior to lysis in human serum-Mg-ethyleneglycol tetraacetic acid. The presence of haemolysin did not reduce the binding or inhibitory activity of C4 bp, and the enhancing activity of haemolysin was retained in serum depleted of C4 bp. By contrast, binding of factor H was greatly reduced in the presence of haemolysin, which had no enhancing effect in serum depleted of factor H. These experiments demonstrate the ability of IgG, IgM and IgA to enhance lectin pathway cytolysis, and that this enhancement occurs by neutralization of the inhibitory activity of factor H. Immunoglobulin enhancement of lectin pathway cytolysis represents another interaction between the innate and adaptive systems of immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469044      PMCID: PMC1905381          DOI: 10.1046/j.1365-2249.1999.00996.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.

Authors:  Y H Ji; M Matsushita; H Okada; T Fujita; M Kawakami
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

2.  Passive immune lysis with chromic chloride-treated erythrocytes.

Authors:  P J Perucca; W P Faulk; H H Fudenberg
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

3.  C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.

Authors:  C Mold; M Kingzette; H Gewurz
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

Review 4.  The role of antibody in the activation of the alternative complement pathway.

Authors:  W D Ratnoff; D T Fearon; K F Austen
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Authors:  C Suankratay; C Mold; Y Zhang; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Isolation and characterization of a mannan-binding protein from human serum.

Authors:  N Kawasaki; T Kawasaki; I Yamashina
Journal:  J Biochem       Date:  1983-09       Impact factor: 3.387

7.  Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.

Authors:  K A Joiner; R C Goldman; C H Hammer; L Leive; M M Frank
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.

Authors:  K A Joiner; R C Goldman; C H Hammer; L Leive; M M Frank
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

9.  Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.

Authors:  M E Medof; T Lam; G M Prince; C Mold
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.

Authors:  L F Fries; T A Gaither; C H Hammer; M M Frank
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  3 in total

1.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

2.  Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.

Authors:  C Suankratay; C Mold; Y Zhang; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

3.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.